Veterans Infertility Treatment Act of 2025
HB220, the Veterans Infertility Treatment Act of 2025, would require the Department of Veterans Affairs to provide infertility treatment and standard fertility preservation services to eligible veterans and certain partners of veterans. Covered services include assisted reproductive technology, including in vitro fertilization, as well as the procurement, cryopreservation, and storage of gametes and embryos. The bill also allows the VA to use donated gametes or embryos, sets a cap of three completed IVF cycles resulting in live birth or 10 attempted cycles, whichever comes first, and requires consent from the veteran, the partner where applicable, and any third-party donor.
The bill creates a new section in title 38 of the U.S. Code and directs the VA to issue implementing regulations within one year of enactment. It also provides transitional rules so people already receiving infertility counseling or treatment under existing VA authority can continue care or move into the new program, and it temporarily expands current authority to cover unmarried partners and donated gametes or embryos before final regulations are issued. The measure expressly states that it does not require the VA to provide maternity care beyond what is already required by law.
HB220 would amend title 38 to add a new VA health-care entitlement for infertility treatment and fertility preservation, expanding the scope of benefits available to enrolled veterans who have infertility or are at risk of infertility due to medical conditions or treatments such as chemotherapy, radiation, surgery, or medication therapy. It would also affect travel reimbursement rules by treating a veteran’s partner as a veteran for purposes of beneficiary travel when receiving covered services. The bill preserves state-law control over the legal status, custody, future use, donation, disposition, or destruction of gametes and embryos, meaning those issues would continue to be governed by the law of the state where the gametes or embryos are located.
Based on the bill text and available context, the measure appears to have a generally supportive, pro-benefit orientation, with bipartisan-style coalition sponsorship from a large group of House members. There are no recorded committee transcripts or votes in the provided material, so there is no documented floor or committee debate to indicate formal opposition or support levels. The bill’s framing suggests it is intended to expand access to reproductive health care for veterans and to modernize VA benefits for those facing infertility or fertility-threatening medical treatment.
The main areas where disagreement could arise are the scope of VA coverage, the use of assisted reproductive technology, and the treatment of embryos, gametes, and partner eligibility. The bill allows IVF using donated gametes or embryos and extends coverage to partners, including unmarried partners during the interim period, which may draw policy or moral objections from critics of assisted reproduction or from those concerned about family-status definitions. Another possible point of contention is the interaction with state law: while the bill defers to state law on embryo and gamete disposition, that choice could still raise concerns about inconsistent treatment across states. No specific objections are documented in the provided committee or vote history.